Financhill
Sell
50

SPOK Quote, Financials, Valuation and Earnings

Last price:
$13.64
Seasonality move :
2.66%
Day range:
$13.32 - $13.78
52-week range:
$12.26 - $19.31
Dividend yield:
9.08%
P/E ratio:
17.21x
P/S ratio:
2.05x
P/B ratio:
1.91x
Volume:
124.8K
Avg. volume:
166K
1-year change:
-14.53%
Market cap:
$283.6M
Revenue:
$137.7M
EPS (TTM):
$0.80

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SPOK
Spok Holdings, Inc.
$34.6M $0.24 2.09% 18.18% $20.00
CERT
Certara, Inc.
$103.2M $0.10 4.37% 380.88% $12.38
DRIO
DarioHealth Corp.
$5M -$1.59 -24.79% -245.23% $18.00
FORA
Forian, Inc.
$7.7M $0.01 32.51% 56.25% $2.10
GDRX
GoodRx Holdings, Inc.
$193.3M $0.09 -3.87% 227.11% $4.56
NRC
National Research Corp.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SPOK
Spok Holdings, Inc.
$13.77 $20.00 $283.6M 17.21x $0.31 9.08% 2.05x
CERT
Certara, Inc.
$8.79 $12.38 $1.4B 130.22x $0.00 0% 3.41x
DRIO
DarioHealth Corp.
$10.02 $18.00 $24M -- $0.00 0% 5.56x
FORA
Forian, Inc.
$2.10 $2.10 $65.3M 49.00x $0.00 0% 2.33x
GDRX
GoodRx Holdings, Inc.
$2.27 $4.56 $770.5M 26.43x $0.00 0% 1.04x
NRC
National Research Corp.
$20.34 -- $460.9M 28.86x $0.16 2.56% 3.33x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SPOK
Spok Holdings, Inc.
4.71% 0.991 2.07% 0.97x
CERT
Certara, Inc.
22.36% 0.446 15.74% 1.94x
DRIO
DarioHealth Corp.
29.69% 1.483 75.99% 3.72x
FORA
Forian, Inc.
0.06% 0.694 0.03% 3.58x
GDRX
GoodRx Holdings, Inc.
47.58% 0.610 37.77% 2.62x
NRC
National Research Corp.
84.83% 2.268 28.57% 0.39x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SPOK
Spok Holdings, Inc.
$20M $4.5M 10.33% 10.88% 13.38% $7.6M
CERT
Certara, Inc.
$50.9M $6.8M 0.79% 1.02% 6.53% $25.5M
DRIO
DarioHealth Corp.
$3M -$9.5M -28.66% -41.55% -189.42% -$7.4M
FORA
Forian, Inc.
$4M -$299.3K -2.24% -2.86% -3.86% -$439.7K
GDRX
GoodRx Holdings, Inc.
$161.2M $26.4M 2.63% 4.78% 13.48% $58M
NRC
National Research Corp.
$20M $7.7M 17.01% 61.55% 22.36% $10.2M

Spok Holdings, Inc. vs. Competitors

  • Which has Higher Returns SPOK or CERT?

    Certara, Inc. has a net margin of 9.46% compared to Spok Holdings, Inc.'s net margin of 1.46%. Spok Holdings, Inc.'s return on equity of 10.88% beat Certara, Inc.'s return on equity of 1.02%.

    Company Gross Margin Earnings Per Share Invested Capital
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
    CERT
    Certara, Inc.
    48.67% $0.01 $1.4B
  • What do Analysts Say About SPOK or CERT?

    Spok Holdings, Inc. has a consensus price target of $20.00, signalling upside risk potential of 52.51%. On the other hand Certara, Inc. has an analysts' consensus of $12.38 which suggests that it could grow by 40.79%. Given that Spok Holdings, Inc. has higher upside potential than Certara, Inc., analysts believe Spok Holdings, Inc. is more attractive than Certara, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SPOK
    Spok Holdings, Inc.
    1 0 0
    CERT
    Certara, Inc.
    7 6 0
  • Is SPOK or CERT More Risky?

    Spok Holdings, Inc. has a beta of 0.415, which suggesting that the stock is 58.512% less volatile than S&P 500. In comparison Certara, Inc. has a beta of 1.474, suggesting its more volatile than the S&P 500 by 47.354%.

  • Which is a Better Dividend Stock SPOK or CERT?

    Spok Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 9.08%. Certara, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spok Holdings, Inc. pays 171.77% of its earnings as a dividend. Certara, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SPOK or CERT?

    Spok Holdings, Inc. quarterly revenues are $33.9M, which are smaller than Certara, Inc. quarterly revenues of $104.6M. Spok Holdings, Inc.'s net income of $3.2M is higher than Certara, Inc.'s net income of $1.5M. Notably, Spok Holdings, Inc.'s price-to-earnings ratio is 17.21x while Certara, Inc.'s PE ratio is 130.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spok Holdings, Inc. is 2.05x versus 3.41x for Certara, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SPOK
    Spok Holdings, Inc.
    2.05x 17.21x $33.9M $3.2M
    CERT
    Certara, Inc.
    3.41x 130.22x $104.6M $1.5M
  • Which has Higher Returns SPOK or DRIO?

    DarioHealth Corp. has a net margin of 9.46% compared to Spok Holdings, Inc.'s net margin of -41.48%. Spok Holdings, Inc.'s return on equity of 10.88% beat DarioHealth Corp.'s return on equity of -41.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
    DRIO
    DarioHealth Corp.
    60.22% -$3.05 $106.6M
  • What do Analysts Say About SPOK or DRIO?

    Spok Holdings, Inc. has a consensus price target of $20.00, signalling upside risk potential of 52.51%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 79.64%. Given that DarioHealth Corp. has higher upside potential than Spok Holdings, Inc., analysts believe DarioHealth Corp. is more attractive than Spok Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SPOK
    Spok Holdings, Inc.
    1 0 0
    DRIO
    DarioHealth Corp.
    3 1 0
  • Is SPOK or DRIO More Risky?

    Spok Holdings, Inc. has a beta of 0.415, which suggesting that the stock is 58.512% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.

  • Which is a Better Dividend Stock SPOK or DRIO?

    Spok Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 9.08%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spok Holdings, Inc. pays 171.77% of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SPOK or DRIO?

    Spok Holdings, Inc. quarterly revenues are $33.9M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Spok Holdings, Inc.'s net income of $3.2M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, Spok Holdings, Inc.'s price-to-earnings ratio is 17.21x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spok Holdings, Inc. is 2.05x versus 5.56x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SPOK
    Spok Holdings, Inc.
    2.05x 17.21x $33.9M $3.2M
    DRIO
    DarioHealth Corp.
    5.56x -- $5M -$2.1M
  • Which has Higher Returns SPOK or FORA?

    Forian, Inc. has a net margin of 9.46% compared to Spok Holdings, Inc.'s net margin of -1.95%. Spok Holdings, Inc.'s return on equity of 10.88% beat Forian, Inc.'s return on equity of -2.86%.

    Company Gross Margin Earnings Per Share Invested Capital
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
    FORA
    Forian, Inc.
    50.97% -$0.00 $31.1M
  • What do Analysts Say About SPOK or FORA?

    Spok Holdings, Inc. has a consensus price target of $20.00, signalling upside risk potential of 52.51%. On the other hand Forian, Inc. has an analysts' consensus of $2.10 which suggests that it could fall by --. Given that Spok Holdings, Inc. has higher upside potential than Forian, Inc., analysts believe Spok Holdings, Inc. is more attractive than Forian, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SPOK
    Spok Holdings, Inc.
    1 0 0
    FORA
    Forian, Inc.
    0 1 0
  • Is SPOK or FORA More Risky?

    Spok Holdings, Inc. has a beta of 0.415, which suggesting that the stock is 58.512% less volatile than S&P 500. In comparison Forian, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SPOK or FORA?

    Spok Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 9.08%. Forian, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spok Holdings, Inc. pays 171.77% of its earnings as a dividend. Forian, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SPOK or FORA?

    Spok Holdings, Inc. quarterly revenues are $33.9M, which are larger than Forian, Inc. quarterly revenues of $7.8M. Spok Holdings, Inc.'s net income of $3.2M is higher than Forian, Inc.'s net income of -$151.2K. Notably, Spok Holdings, Inc.'s price-to-earnings ratio is 17.21x while Forian, Inc.'s PE ratio is 49.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spok Holdings, Inc. is 2.05x versus 2.33x for Forian, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SPOK
    Spok Holdings, Inc.
    2.05x 17.21x $33.9M $3.2M
    FORA
    Forian, Inc.
    2.33x 49.00x $7.8M -$151.2K
  • Which has Higher Returns SPOK or GDRX?

    GoodRx Holdings, Inc. has a net margin of 9.46% compared to Spok Holdings, Inc.'s net margin of 0.57%. Spok Holdings, Inc.'s return on equity of 10.88% beat GoodRx Holdings, Inc.'s return on equity of 4.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
    GDRX
    GoodRx Holdings, Inc.
    82.22% $0.00 $1.1B
  • What do Analysts Say About SPOK or GDRX?

    Spok Holdings, Inc. has a consensus price target of $20.00, signalling upside risk potential of 52.51%. On the other hand GoodRx Holdings, Inc. has an analysts' consensus of $4.56 which suggests that it could grow by 100.91%. Given that GoodRx Holdings, Inc. has higher upside potential than Spok Holdings, Inc., analysts believe GoodRx Holdings, Inc. is more attractive than Spok Holdings, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    SPOK
    Spok Holdings, Inc.
    1 0 0
    GDRX
    GoodRx Holdings, Inc.
    4 6 0
  • Is SPOK or GDRX More Risky?

    Spok Holdings, Inc. has a beta of 0.415, which suggesting that the stock is 58.512% less volatile than S&P 500. In comparison GoodRx Holdings, Inc. has a beta of 1.497, suggesting its more volatile than the S&P 500 by 49.715%.

  • Which is a Better Dividend Stock SPOK or GDRX?

    Spok Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 9.08%. GoodRx Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Spok Holdings, Inc. pays 171.77% of its earnings as a dividend. GoodRx Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SPOK or GDRX?

    Spok Holdings, Inc. quarterly revenues are $33.9M, which are smaller than GoodRx Holdings, Inc. quarterly revenues of $196M. Spok Holdings, Inc.'s net income of $3.2M is higher than GoodRx Holdings, Inc.'s net income of $1.1M. Notably, Spok Holdings, Inc.'s price-to-earnings ratio is 17.21x while GoodRx Holdings, Inc.'s PE ratio is 26.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spok Holdings, Inc. is 2.05x versus 1.04x for GoodRx Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SPOK
    Spok Holdings, Inc.
    2.05x 17.21x $33.9M $3.2M
    GDRX
    GoodRx Holdings, Inc.
    1.04x 26.43x $196M $1.1M
  • Which has Higher Returns SPOK or NRC?

    National Research Corp. has a net margin of 9.46% compared to Spok Holdings, Inc.'s net margin of 11.54%. Spok Holdings, Inc.'s return on equity of 10.88% beat National Research Corp.'s return on equity of 61.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    SPOK
    Spok Holdings, Inc.
    58.95% $0.15 $156.1M
    NRC
    National Research Corp.
    57.82% $0.18 $94.4M
  • What do Analysts Say About SPOK or NRC?

    Spok Holdings, Inc. has a consensus price target of $20.00, signalling upside risk potential of 52.51%. On the other hand National Research Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Spok Holdings, Inc. has higher upside potential than National Research Corp., analysts believe Spok Holdings, Inc. is more attractive than National Research Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    SPOK
    Spok Holdings, Inc.
    1 0 0
    NRC
    National Research Corp.
    0 0 0
  • Is SPOK or NRC More Risky?

    Spok Holdings, Inc. has a beta of 0.415, which suggesting that the stock is 58.512% less volatile than S&P 500. In comparison National Research Corp. has a beta of 0.490, suggesting its less volatile than the S&P 500 by 50.981%.

  • Which is a Better Dividend Stock SPOK or NRC?

    Spok Holdings, Inc. has a quarterly dividend of $0.31 per share corresponding to a yield of 9.08%. National Research Corp. offers a yield of 2.56% to investors and pays a quarterly dividend of $0.16 per share. Spok Holdings, Inc. pays 171.77% of its earnings as a dividend. National Research Corp. pays out 45.99% of its earnings as a dividend. National Research Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Spok Holdings, Inc.'s is not.

  • Which has Better Financial Ratios SPOK or NRC?

    Spok Holdings, Inc. quarterly revenues are $33.9M, which are smaller than National Research Corp. quarterly revenues of $34.6M. Spok Holdings, Inc.'s net income of $3.2M is lower than National Research Corp.'s net income of $4M. Notably, Spok Holdings, Inc.'s price-to-earnings ratio is 17.21x while National Research Corp.'s PE ratio is 28.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Spok Holdings, Inc. is 2.05x versus 3.33x for National Research Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SPOK
    Spok Holdings, Inc.
    2.05x 17.21x $33.9M $3.2M
    NRC
    National Research Corp.
    3.33x 28.86x $34.6M $4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Alerts

Sell
40
GDXU alert for Feb 2

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 1.63% over the past day.

Sell
34
PFSI alert for Feb 2

PennyMac Financial Services, Inc. [PFSI] is down 6.76% over the past day.

Sell
40
SHNY alert for Feb 2

MicroSectors Gold 3X Leveraged ETN [SHNY] is down 11.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock